Supernus Pharmaceuticals SUPN Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Supernus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Supernus Pharmaceuticals's prepaid & other current?
- Supernus Pharmaceuticals (SUPN) reported prepaid & other current of $78.09M in Q1 2026.
- How has Supernus Pharmaceuticals's prepaid & other current changed year-over-year?
- Supernus Pharmaceuticals's prepaid & other current increased by 169.9% year-over-year, from $28.93M to $78.09M.
- What is the long-term trend for Supernus Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), Supernus Pharmaceuticals's prepaid & other current has grown at a 28.4% compound annual growth rate (CAGR), from $18.68M to $65.33M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.